一个不依赖于甲基胺的途径控制了适应性脂肪细胞脂解
Xiao Zhang1,2, Sreejith S Panicker1,2, Jordan M Bollinger1,2
1Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Nature metabolism
|January 8, 2026
概括
身体可以通过一种新的途径快速分解所有脂肪,包括固的骨髓脂肪. 这个过程独立于食物摄入,涉及低血糖和胰岛素,激活脂肪分解.
科学领域:
- 代谢过程中的代谢.
- 内分泌学 在内分泌学.
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 构成骨髓的脂肪组织和其他脂肪储存物抵制典型的脂肪分解信号.
- 身体在饥饿,消耗或缓解中对稳定的脂肪细胞进行代谢的机制在很大程度上是未知的.
研究的目的:
- 调查稳定的脂肪细胞,特别是骨髓脂肪组织的代谢机制,独立于食物摄入.
- 为了确定调节所有脂肪组织枯竭的神经系统途径.
主要方法:
- 开发一种用于脑引起的脂肪消耗的新型小鼠模型.
- 利用遗传学,手术和化学方法研究脂肪细胞代谢.
- 研究了脂解,局部神经,交感神经系统,甲基荷胺,低血糖和低胰岛素血的作用.
主要成果:
- 脂肪甘油三糖 lipase依赖性脂解对于稳定的脂肪细胞代谢至关重要.
- 催化剂是独立于局部神经,交感神经系统,和catecholamines.
- 同时出现的低血糖和低胰岛素症会通过抑制脂质储存并通过降低像G0s2.2.这样的抑制剂的下调来促进catecholamine独立的脂质分解,从而触发催化状态.
- 这一途径有效地去除了经典的脂肪储存,并且在卡塞克斯小鼠中观察到.
结论:
- 稳定的脂肪细胞在健康状态下具有独特的抗脂解机制.
- 在特定的生理条件下,一种强大的甲基胺独立的神经系统通路促进所有脂肪组织的快速代谢.
- 这条通路由低血糖和低胰岛素血症激活,并且与卡赫克西亚等疾病相关.
相关概念视频
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
Adrenergic Neurons: Neurotransmission
5.1K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.1K
Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K
Adrenergic Receptors: β Subtype
3.4K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.4K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Adrenergic Agonists: Indirect-Acting Agents
2.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.6K


